Catalyst Wire Dossier Catalyst Wire Dossier

Pyrotinib maleate tablets

pyrotinib
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pyrotinib maleate tablets, covering 2022-03-10 to 2022-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer [Phase 2]

See pricing